Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have had a dual-chamber permanent pacemaker or defibrillator (a device with two leads implanted in the heart) fitted within the last 10 years
Who may not be able to join:
- People who have been diagnosed with atrial fibrillation (an irregular heart rhythm) confirmed by a heart tracing test such as an ECG, telemetry monitor, or Holter monitor
- People whose doctor considers them unsuitable because they have another illness that means their life expectancy is less than 2 years
- People who are currently pregnant or breastfeeding
- People who were born with a structural heart condition (congenital heart disease)
- People who have an inherited heart rhythm condition, such as Brugada syndrome or long QT syndrome
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Pablo Nery, MD, Ottawa Heart Institute Research Corporation
Phone: 613-696-7000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The development of new Sub-Clinical Atrial Fibrillation as recorded on implanted devices; Sub-clinical Atrial Fibrillation as predicted by biomarkers
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.